Recently, a delegation of African and South Asian public officers currently pursuing postgraduate studies at Sun Yat-sen University visited Pluslife for an insightful company and factory tour. The visit aimed to foster knowledge of the rapidly growing In Vitro Diagnostics (IVD) industry and develop a comprehensive understanding of the Pluslife company.

During the engaging meeting, Pluslife's representatives shared expertise on various aspects of the IVD industry, from technological advancements to the global market landscape, providing the delegation with a general understanding of the IVD industry.

A highlight of the visit was the introduction of Pluslife's innovative molecular POCT diagnostics. The delegation learned about the applications of these cutting-edge diagnostics in global primary healthcare settings, with specific examples from countries such as Kenya, Indonesia, and India. Given the pressing need for affordable, rapid, and accurate diagnostic tools in African and South Asian primary healthcare markets, the Pluslife products were met with keen interest.

The delegation was particularly impressed with the factory tour, where they witnessed firsthand the technological advancements and innovations that have propelled Pluslife's growth over the past 5-6 years. The tour showcased Pluslife's commitment to quality and efficiency in the production of molecular POCT diagnostics solutions.

Several members of the delegation expressed the need for molecular POCT products in their respective countries. Recognizing the potential impact of Pluslife molecular POCT solutions, they voiced their desire to introduce these products to their healthcare systems. They believe that incorporating Pluslife's technology would enhance healthcare outcomes by providing timely and accurate screening and diagnostics to their communities. The visit sparked discussions about potential collaborations and partnerships between Pluslife and the public sectors in African and South Asian countries.

As Pluslife continues to make strides in the realm of molecular diagnostics, the visit from the African and South Asian public officers marks an important step towards potential international collaborations that align with WHO’s strategies. The shared vision of improving primary healthcare in the LMICs through Pluslife’s innovative molecular POCT solutions opens doors for prospective collaborations, with the potential to make a positive impact on global healthcare accessibility.